Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
29.91
+0.35 (1.18%)
At close: Dec 5, 2025, 4:00 PM EST
29.92
0.00 (0.02%)
After-hours: Dec 5, 2025, 5:01 PM EST

Centessa Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
15-6.85---
Upgrade
Gross Profit
15-6.85---
Upgrade
Selling, General & Admin
50.1850.8153.7355.243.011.14
Upgrade
Research & Development
178.62150.24124.41155.0896.329.3
Upgrade
Operating Expenses
228.8201.06178.14210.28139.3310.44
Upgrade
Operating Income
-213.8-201.06-171.28-210.28-139.33-10.44
Upgrade
Interest Expense
-11.13-10.09-9.91-7.28-2.55-0.38
Upgrade
Interest & Investment Income
20.8814.0210.480.24--
Upgrade
Currency Exchange Gain (Loss)
-1.3-1.80.8-2.8-3.6-
Upgrade
Other Non Operating Income (Expenses)
0.140.11-0.33-0.76-0.770.16
Upgrade
EBT Excluding Unusual Items
-205.21-198.82-170.24-220.87-146.25-10.66
Upgrade
Other Unusual Items
-34.1-34.1-5.93.92-15.08-
Upgrade
Pretax Income
-239.31-232.91-176.14-216.95-381.79-10.66
Upgrade
Income Tax Expense
3.392.84-25.06-0.750.11-
Upgrade
Net Income
-242.7-235.76-151.09-216.21-381.9-10.66
Upgrade
Preferred Dividends & Other Adjustments
-----0.83-
Upgrade
Net Income to Common
-242.7-235.76-151.09-216.21-381.07-10.66
Upgrade
Shares Outstanding (Basic)
13311496937515
Upgrade
Shares Outstanding (Diluted)
13311496937515
Upgrade
Shares Change (YoY)
25.82%19.02%2.97%24.26%401.11%-
Upgrade
EPS (Basic)
-1.82-2.06-1.57-2.31-5.07-0.71
Upgrade
EPS (Diluted)
-1.82-2.06-1.57-2.31-5.07-0.71
Upgrade
Free Cash Flow
-181.17-142.09-160.51-201.68-136.34-10.63
Upgrade
Free Cash Flow Per Share
-1.36-1.24-1.67-2.16-1.81-0.71
Upgrade
Gross Margin
100.00%-100.00%---
Upgrade
Operating Margin
-1425.33%--2499.39%---
Upgrade
Profit Margin
-1617.99%--2204.66%---
Upgrade
Free Cash Flow Margin
-1207.80%--2342.20%---
Upgrade
EBITDA
-213.49-200.71-170.97-210.15-139.3-10.43
Upgrade
D&A For EBITDA
0.310.340.310.130.030.01
Upgrade
EBIT
-213.8-201.06-171.28-210.28-139.33-10.44
Upgrade
Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q